Hamang Anniken, Solberg Berge, Bjorvatn Cathrine, Greve Gottfried, Øyen Nina
Senter for medisinsk genetikk og molekylaermedisin, Haukeland universitetssykehus, 5021 Bergen.
Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1226-9. doi: 10.4045/tidsskr.09.32621.
Long QT syndrome is an inherited heart-rhythm disorder characterized by an increased risk of ventricular tachycardia and sudden death. Genetic testing is available.
The article is based on an anonymous family with a history of long QT syndrome, the authors experience with this patient group and a Pubmed search for literature from the period 1957 - 2007.
An 8-year-old boy suffers syncope at a sports event, and this leads to genetic counseling and molecular genetic testing of his first-and second-degree relatives. Knowledge about genetic risk of sudden death in a family can trigger genetic testing and health preventive treatment of children, but can also have substantial psychosocial and ethical consequences for the family and for the health-care personnel involved.
Living with a genetic risk can be very emotionally challenging for the individuals and families, and "The Norwegian Act of Biotechnology in Human Medicine, etc" that regulates clinical genetic activities is extensive. An important question is whether the current Act allows communication of genetic information to persons other than the patient.
长QT综合征是一种遗传性心律失常疾病,其特征是室性心动过速和猝死风险增加。可进行基因检测。
本文基于一个有长QT综合征病史的匿名家庭、作者对该患者群体的经验以及对1957年至2007年期间文献的PubMed检索。
一名8岁男孩在体育活动中晕厥,这导致对其一级和二级亲属进行遗传咨询和分子基因检测。了解家族中猝死的遗传风险可促使对儿童进行基因检测和健康预防性治疗,但也可能给相关家庭和医护人员带来重大的心理社会和伦理后果。
对于个人和家庭而言,面对遗传风险在情感上可能极具挑战性,且规范临床遗传活动的《挪威人类医学中的生物技术法案》等内容广泛。一个重要问题是,现行法案是否允许将遗传信息告知患者以外的其他人。